data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Vaccitech
(NASDAQ:VACC)
$2.37
At close: Nov 28(Delayed 15-Minutes)
Get Real Time Here
$2.30
-0.0700[-2.95%]
PreMarket: 4:09AM EDT
Day Range- - -52 Wk Range- - 12.2Open / Close- / -Float / Outstanding34.4M / 37.3M
Vol / Avg.- / 56.3KMkt Cap88.4MP/E7.6550d Avg. Price2.78
Div / Yield-Payout Ratio-Total Float34.4MEPS0.22

Vaccitech Stock (NASDAQ:VACC), Quotes and News Summary

Vaccitech Stock (NASDAQ: VACC) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range- - 12.2Open / Close- / -Float / Outstanding34.4M / 37.3M
Vol / Avg.- / 56.3KMkt Cap88.4MP/E7.6550d Avg. Price2.78
Div / Yield-Payout Ratio-Total Float34.4MEPS0.22
Globe Newswire - Nov 21, 2022, 10:31AM
Globe Newswire - Nov 10, 2022, 4:30PM
Globe Newswire - Nov 9, 2022, 8:00AM
Globe Newswire - Nov 7, 2022, 8:00AM
Globe Newswire - Nov 2, 2022, 8:00AM
Globe Newswire - Oct 31, 2022, 8:00AM
Globe Newswire - Oct 27, 2022, 7:00AM
Globe Newswire - Oct 3, 2022, 4:30PM
Globe Newswire - Sep 20, 2022, 4:30PM
Globe Newswire - Sep 7, 2022, 4:01PM
Globe Newswire - Aug 9, 2022, 4:15PM
Globe Newswire - Jul 7, 2022, 4:15PM
Globe Newswire - Jun 22, 2022, 6:00AM
Globe Newswire - Jun 6, 2022, 4:15PM
Globe Newswire - Jun 6, 2022, 7:30AM
Globe Newswire - May 20, 2022, 11:30AM
Globe Newswire - May 11, 2022, 4:15PM
Globe Newswire - Apr 6, 2022, 4:15PM
Globe Newswire - Mar 25, 2022, 7:15AM
Globe Newswire - Mar 7, 2022, 8:00AM
Globe Newswire - Jan 18, 2022, 3:00AM
Globe Newswire - Jan 13, 2022, 4:34PM
Globe Newswire - Dec 13, 2021, 4:05PM
Globe Newswire - Dec 7, 2021, 8:00AM
TipRanks - Nov 14, 2022, 6:30AM
TipRanks - Nov 8, 2022, 6:30AM
TipRanks - Nov 1, 2022, 6:25AM
InvestorsObserver - Oct 31, 2022, 6:55AM
InvestorsObserver - Oct 28, 2022, 7:31AM
TipRanks - Oct 28, 2022, 6:30AM
Seeking Alpha - Oct 27, 2022, 9:02AM
InvestorsObserver - Oct 26, 2022, 8:16AM
InvestorsObserver - Oct 25, 2022, 7:04AM
InvestorsObserver - Oct 24, 2022, 7:49AM
InvestorsObserver - Oct 21, 2022, 7:53AM
InvestorsObserver - Oct 20, 2022, 6:45AM
InvestorsObserver - Oct 19, 2022, 6:37AM
InvestorsObserver - Aug 29, 2022, 10:24AM
TipRanks - Aug 15, 2022, 12:50PM
TipRanks - Aug 11, 2022, 6:25AM
Seeking Alpha - Jun 29, 2022, 3:36PM
TipRanks - Jun 23, 2022, 6:16AM
TipRanks - Jun 7, 2022, 8:05AM
Seeking Alpha - Jun 6, 2022, 9:43AM
TipRanks - May 12, 2022, 12:10PM
TipRanks - Apr 7, 2022, 6:25AM
Seeking Alpha - Apr 6, 2022, 4:54PM
Seeking Alpha - Apr 3, 2022, 7:57PM
Seeking Alpha - Mar 7, 2022, 4:33PM
TipRanks - Jan 19, 2022, 6:22AM
Seeking Alpha - Jan 18, 2022, 7:42AM
TipRanks - Dec 15, 2021, 6:25AM
Seeking Alpha - Dec 13, 2021, 5:12PM
TipRanks - Dec 8, 2021, 9:15AM
Seeking Alpha - Dec 7, 2021, 9:15AM
Seeking Alpha - Dec 2, 2021, 6:03PM
Sector: Health Care.Industry: Biotechnology
Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.3300.220 0.5500
REV7.820M6.165M-1.655M
Q2 2022Est.ActualSurprise
EPS-0.3900.410 0.8000
REV17.063M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Vaccitech (VACC) stock?

A

You can purchase shares of Vaccitech (NASDAQ: VACC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vaccitech's (VACC) competitors?

Q

What is the target price for Vaccitech (VACC) stock?

A

The latest price target for Vaccitech (NASDAQ: VACC) was reported by Morgan Stanley on Monday, August 15, 2022. The analyst firm set a price target for 16.00 expecting VACC to rise to within 12 months (a possible 575.11% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Vaccitech (VACC)?

A

The stock price for Vaccitech (NASDAQ: VACC) is $2.37 last updated November 28, 2022, 8:59 PM UTC.

Q

Does Vaccitech (VACC) pay a dividend?

A

There are no upcoming dividends for Vaccitech.

Q

When is Vaccitech (NASDAQ:VACC) reporting earnings?

A

Vaccitech’s Q3 earnings are confirmed for Thursday, November 10, 2022.

Q

Is Vaccitech (VACC) going to split?

A

There is no upcoming split for Vaccitech.

Q

What sector and industry does Vaccitech (VACC) operate in?

A

Vaccitech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.